Diabetes Medication Satisfaction (DiabMedSat)

[ Distributed by Mapi Research Trust ]

Author(s) Novo Nordisk [ Meryl Brod, Soren E Skovlund, Kim Wittrup-Jensen (initial development and validation study) ]	Purpose   Pathology: Endocrine system diseases Nutritional and metabolic diseases   Disease: Diabetes mellitus [ Type 1 – IDDM, Type 2 – NIDDM, Type 2 – Insulin requiring patients ]   Objective: To measure diabetes treatment satisfaction, applicable to a wide range of diabetes therapies   Population for intended use: Adult	Characteristics   Type of instrument: Patient satisfaction   Administration mode: Self-administered   Number of items: 21   Existence of database: No   Recall/Observation period: Over the past 2 weeks
Language(s)   Original language: English for the USA   List of existing translations: The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors ------------------------------------------------------------------------------------------------------------------------------ Arabic for Israel English for Canada Hindi Russian Cebuano English for the UK Italian Spanish Chinese for Hong Kong Finnish Japanese Spanish for Mexico Chinese for Singapore French Macedonian Swedish Chinese for Taiwan French for Canada Malay for Singapore Swedish for Finland Croatian German Mandarin for China Tagalog Danish German for Austria Marathi Tamil Dutch German for Switzerland Polish Telugu English for Australia Hebrew Portuguese for Brazil Turkish
Last update: June 2009 Last update in collaboration with the author: November 2007

Details of the questionnaire (Restricted access for ProQolid's members)

Subscribe